We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

ANC-501 in the Treatment of Adults With Major Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05439603
Recruitment Status : Recruiting
First Posted : June 30, 2022
Last Update Posted : December 8, 2022
Information provided by (Responsible Party):
Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 25, 2023
Estimated Study Completion Date : March 25, 2023